1179-2736

Journal of Blood Medicine

Dove Medical Press

View prefix report (10.2147)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 727 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact727 DOIs
2

Deposit reference lists for 305 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact305 DOIs
3

Attach ORCID iDs across 254 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact254 DOIs

DOIs for this ISSN

Showing the top 5 of 726 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Hemophagocytic lymphohistiocytosis: review of etiologies and… (10.2147/jbm.s46255)
Abstract References ORCID
190.34 344
2 Homeostatic and pathogenic extramedullary hematopoiesis (10.2147/jbm.s7224)
Abstract References ORCID
171.75 194
3 IDH1 and IDH2 mutations as novel therapeutic targets: curren… (10.2147/jbm.s70716)
Abstract References ORCID
168.04 173
4 Deep vein thrombosis: a clinical review (10.2147/jbm.s19009)
Abstract References ORCID
160.25 136
5 Optimal management of hemophilic arthropathy and hematomas (10.2147/jbm.s50644)
Abstract References ORCID
150.65 101
6 Treatment of hemophilia: a review of current advances and on… (10.2147/jbm.s6885)
Abstract References ORCID
147.64 92
7 Glanzmann's thrombasthenia: pathogenesis, diagnosis,… (10.2147/jbm.s71319)
Abstract References ORCID
147.64 92
8 Many factor VIII products available in the treatment of hemo… (10.2147/jbm.s103796)
Abstract References ORCID
145.09 85
9 Update and new approaches in the treatment of Castleman dise… (10.2147/jbm.s60514)
Abstract References ORCID
143.14 80
10 The challenges of meeting the blood transfusion requirements… (10.2147/jbm.s17194)
Abstract References ORCID
142.32 78
11 Optimal management of pernicious anemia (10.2147/jbm.s25620)
Abstract References ORCID
139.30 71
12 Barriers and perceived limitations to early treatment of hem… (10.2147/jbm.s43734)
Abstract References ORCID
139.30 71
13 Acquired hypofibrinogenemia: current perspectives (10.2147/jbm.s90693)
Abstract References ORCID
136.96 66
14 <p>Platelet Transfusion: And Update on Challenges and… (10.2147/jbm.s234374)
Abstract References ORCID
133.90 60
15 Hematopoietic cell transplantation-associated thrombotic mic… (10.2147/jbm.s102235)
Abstract References ORCID
132.26 57
16 Techniques used for the screening of hemoglobin levels in bl… (10.2147/jbm.s103788)
Abstract References ORCID
131.69 56
17 <p>Managing the risk of venous thromboembolism in tran… (10.2147/jbm.s166780)
Abstract References ORCID
129.93 53
18 <p>Management of refractory autoimmune hemolytic anemi… (10.2147/jbm.s190327)
Abstract References ORCID
128.70 51
19 Reducing the iron burden and improving survival in transfusi… (10.2147/jbm.s61540)
Abstract References ORCID
128.07 50
20 Vascular nitric oxide: formation and function (10.2147/jbm.s7000)
Abstract References ORCID
123.99 44
21 Prevalence of anemia and its associated factors among pregna… (10.2147/jbm.s134932)
Abstract References ORCID
123.26 43
22 Treating thalassemia major-related iron overload: the role o… (10.2147/jbm.s27400)
Abstract References ORCID
123.26 43
23 Clinical applications of therapeutic phlebotomy (10.2147/jbm.s108479)
Abstract References ORCID
120.15 39
24 Biomarkers for the differentiation of anemia and their clini… (10.2147/jbm.s29212)
Abstract References ORCID
119.33 38
25 Hematopoietic stem and progenitor cell harvesting: technical… (10.2147/jbm.s52783)
Abstract References ORCID
117.62 36
26 Iron chelation therapy in transfusion-dependent thalassemia… (10.2147/jbm.s72463)
Abstract References ORCID
117.62 36
27 Contribution of blood platelets to vascular pathology in Alz… (10.2147/jbm.s45071)
Abstract References ORCID
116.72 35
28 Ethical and legal considerations regarding the ownership and… (10.2147/jbm.s36134)
Abstract References ORCID
115.81 34
29 Management of transfusional iron overload – differ… (10.2147/jbm.s13065)
Abstract References ORCID
114.86 33
30 Strategies to encourage physical activity in patients with h… (10.2147/jbm.s84848)
Abstract References ORCID
114.86 33
31 Knowledge, attitude, and practice regarding voluntary blood… (10.2147/jbm.s121460)
Abstract References ORCID
112.89 31
32 Current strategies to minimize the bleeding risk of warfarin (10.2147/jbm.s41404)
Abstract References ORCID
112.89 31
33 Optimal management of hereditary hemorrhagic telangiectasia (10.2147/jbm.s45295)
Abstract References ORCID
112.89 31
34 Animal models of β-hemoglobinopathies: utility and… (10.2147/jbm.s87955)
Abstract References ORCID
112.89 31
35 New developments in the management of congenital Factor XIII… (10.2147/jbm.s32693)
Abstract References ORCID
110.78 29
36 Use of sulodexide in patients with peripheral vascular disea… (10.2147/jbm.s10558)
Abstract References ORCID
109.68 28
37 Hematologic abnormalities and associated factors among HIV i… (10.2147/jbm.s137067)
Abstract References ORCID
109.68 28
38 Barriers in transition from pediatrics to adult medicine in… (10.2147/jbm.s32588)
Abstract References ORCID
109.68 28
39 Management of thrombotic thrombocytopenic purpura: current p… (10.2147/jbm.s46458)
Abstract References ORCID
109.68 28
40 Tranexamic acid for the prevention and management of orthope… (10.2147/jbm.s61915)
Abstract References ORCID
109.68 28
41 Umbilical cord blood banking: from personal donation to inte… (10.2147/jbm.s64090)
Abstract References ORCID
109.68 28
42 Myelodysplastic syndromes/neoplasms: recent classification s… (10.2147/jbm.s12257)
Abstract References ORCID
108.54 27
43 Randomized double blind trial of ciprofloxacin prophylaxis d… (10.2147/jbm.s33906)
Abstract References ORCID
108.54 27
44 Update on argatroban for the prophylaxis and treatment of he… (10.2147/jbm.s38762)
Abstract References ORCID
108.54 27
45 Serum ferritin levels in adults with sickle cell disease in… (10.2147/jbm.s42212)
Abstract References ORCID
108.54 27
46 Midostaurin: an emerging treatment for acute myeloid leukemi… (10.2147/jbm.s100283)
Abstract References ORCID
107.35 26
47 Physical and psychosocial challenges in adult hemophilia pat… (10.2147/jbm.s63265)
Abstract References ORCID
107.35 26
48 Beta-amyloidolysis and glutathione in Alzheimer's di… (10.2147/jbm.s35496)
Abstract References ORCID
106.12 25
49 Hemophilia A in Brazil – epidemiology and treatmen… (10.2147/jbm.s68234)
Abstract References ORCID
106.12 25
50 Acquired hemophilia A: emerging treatment options (10.2147/jbm.s77332)
Abstract References ORCID
106.12 25